References analysis of the Wikipedia article "Beta-amiloide" in the Galician version

amjpathol.org

ajp.amjpathol.org

dddmag.com

Gandy S, Simon AJ, Steele JW, Lublin AL, Lah JJ, Walker LC, Levey AI, Krafft GA, Levy EF, Checler F, Glabe C, Bilker W, Abel T, Schmeidler J, Ehrlich ME (2010). "Days-to-criterion as an indicator of toxicity associated with human Alzheimer amyloid-β oligomers". Annals of Neurology 67 (6): 220–30. PMC 3094694. PMID 20641005. doi:10.1002/ana.22052. Resumo divulgativo – Drug Discovery and Development.

doi.org

dx.doi.org

Vivekanandan S, Brender JR, Lee SY, Ramamoorthy A (July 2011). "A partially folded structure of amyloid-beta(1-40) in an aqueous environment". Biochem. Biophys. Res. Commun. 411 (2): 312–6. PMC 3148408. PMID 21726530. doi:10.1016/j.bbrc.2011.06.133.

Sarkar IN, Tharp G (April 2013). "Origins of amyloid-beta.". BMC Genomics 14 (1): 290. PMID 23627794. doi:10.1186/1471-2164-14-290.

Hiltunen M, van Groen T, Jolkkonen J (2009). "Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: evidence from experimental studies". J. Alzheimers Dis. 18 (2): 401–12. PMID 19584429. doi:10.3233/JAD-2009-1154.

Luo Y, Bolon B, Damore MA, Fitzpatrick D, Liu H, Zhang J, Yan Q, Vassar R, Citron M (October 2003). "BACE1 (beta-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time". Neurobiol. Dis. 14 (1): 81–8. PMID 13678669. doi:10.1016/S0969-9961(03)00104-9.

Bogoyevitch MA, Boehm I, Oakley A, Ketterman AJ, Barr RK (March 2004). "Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential". Biochim. Biophys. Acta 1697 (1–2): 89–101. PMID 15023353. doi:10.1016/j.bbapap.2003.11.016.

Tabaton M, Zhu X, Perry G, Smith MA, Giliberto L (January 2010). "Signaling Effect of Amyloid-β42 on the Processing of AβPP". Exp. Neurol. 221 (1): 18–25. PMC 2812589. PMID 19747481. doi:10.1016/j.expneurol.2009.09.002.

Baruch-Suchodolsky R, Fischer B (May 2009). "Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems". Biochemistry 48 (20): 4354–70. PMID 19320465. doi:10.1021/bi802361k.

Yao ZX, Papadopoulos V (October 2002). "Function of beta-amyloid in cholesterol transport: a lead to neurotoxicity". FASEB J. 16 (12): 1677–9. PMID 12206998. doi:10.1096/fj.02-0285fje.

Igbavboa U, Sun GY, Weisman GA, He Y, Wood WG (August 2009). "Amyloid β-Protein Stimulates Trafficking of Cholesterol and Caveolin-1 from the Plasma Membrane to the Golgi Complex in Mouse Primary Astrocytes". Neuroscience 162 (2): 328–38. PMC 3083247. PMID 19401218. doi:10.1016/j.neuroscience.2009.04.049.

Maloney B, Lahiri DK (June 2011). "The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: Characterizing a new regulatory motif". Gene 488 (1–2): 1–12. PMC 3381326. PMID 21699964. doi:10.1016/j.gene.2011.06.004.

Bailey JA, Maloney B, Ge YW, Lahiri DK (June 2011). "Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis". Gene 488 (1–2): 13–22. PMC 3372404. PMID 21708232. doi:10.1016/j.gene.2011.06.017.

Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD (2010). Bush, Ashley I., ed. "The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide". PLoS ONE 5 (3): e9505. Bibcode:2010PLoSO...5.9505S. PMC 2831066. PMID 20209079. doi:10.1371/journal.pone.0009505.

Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, Nagelhus EA, Nedergaard M (August 2012). "A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β". Sci Transl Med 4 (147): 147ra111. PMC 3551275. PMID 22896675. doi:10.1126/scitranslmed.3003748.

Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O’Donne J, Christensen DJ, Nicholson C, Iliff JJ, Takano T, Deane R, Nedergaard M (2013). "Sleep Drives Metabolite Clearance from the Adult Brain". Science 342 (6156): 373–377. doi:10.1126/science.1241224.

Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (August 2008). "Amyloid β-Protein Dimers Isolated Directly from Alzheimer Brains Impair Synaptic Plasticity and Memory". Nat. Med. 14 (8): 837–42. PMC 2772133. PMID 18568035. doi:10.1038/nm1782. Resumo divulgativo – Fox News.

Prelli F, Castaño E, Glenner GG, Frangione B (August 1988). "Differences between vascular and plaque core amyloid in Alzheimer's disease". J. Neurochem. 51 (2): 648–51. PMID 3292706. doi:10.1111/j.1471-4159.1988.tb01087.x.

Zhao LN, Long H, Mu Y, Chew LY (2012). "The Toxicity of Amyloid β Oligomers". Int J Mol Sci 13 (6): 7303–27. PMC 3397527. PMID 22837695. doi:10.3390/ijms13067303.

Ghiso J, Frangione B (December 2002). "Amyloidosis and Alzheimer's disease". Adv. Drug Deliv. Rev. 54 (12): 1539–51. PMID 12453671. doi:10.1016/S0169-409X(02)00149-7.

Selkoe DJ (October 2001). "Clearing the brain's amyloid cobwebs". Neuron 32 (2): 177–80. PMID 11683988. doi:10.1016/S0896-6273(01)00475-5.

Hardy J, Duff K, Hardy KG, Perez-Tur J, Hutton M (September 1998). "Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau". Nat. Neurosci. 1 (5): 355–8. PMID 10196523. doi:10.1038/1565.

Roses AD (February 1998). "Alzheimer diseases: a model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases". Am. J. Med. Genet. 81 (1): 49–57. PMID 9514588. doi:10.1002/(SICI)1096-8628(19980207)81:1<49::AID-AJMG10>3.0.CO;2-W.

Ray WJ, Yao M, Mumm J, Schroeter EH, Saftig P, Wolfe M, Selkoe DJ, Kopan R, Goate AM (December 1999). "Cell surface presenilin-1 participates in the gamma-secretase-like proteolysis of Notch". J. Biol. Chem. 274 (51): 36801–7. PMID 10593990. doi:10.1074/jbc.274.51.36801.

Roberts SB (December 2002). "γ-secretase inhibitors and Alzheimer's disease". Adv. Drug Deliv. Rev. 54 (12): 1579–88. PMID 12453675. doi:10.1016/S0169-409X(02)00155-2.

Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (October 1999). "Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE". Science 286 (5440): 735–41. PMID 10531052. doi:10.1126/science.286.5440.735.

Vassar R (December 2002). "Beta-secretase (BACE) as a drug target for Alzheimer's disease". Adv. Drug Deliv. Rev. 54 (12): 1589–602. PMID 12453676. doi:10.1016/S0169-409X(02)00157-6.

Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (June 1985). "Amyloid plaque core protein in Alzheimer disease and Down syndrome". Proc. Natl. Acad. Sci. U.S.A. 82 (12): 4245–9. Bibcode:1985PNAS...82.4245M. PMC 397973. PMID 3159021. doi:10.1073/pnas.82.12.4245.

Castaño EM, Prelli F, Soto C, Beavis R, Matsubara E, Shoji M, Frangione B (December 1996). "The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease". J. Biol. Chem. 271 (50): 32185–91. PMID 8943274. doi:10.1074/jbc.271.50.32185.

Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, Ball MJ (November 1993). "beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease". Proc. Natl. Acad. Sci. U.S.A. 90 (22): 10836–40. Bibcode:1993PNAS...9010836R. PMC 47873. PMID 8248178. doi:10.1073/pnas.90.22.10836.

Shinkai Y, Yoshimura M, Ito Y, Odaka A, Suzuki N, Yanagisawa K, Ihara Y (September 1995). "Amyloid beta-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels". Ann. Neurol. 38 (3): 421–8. PMID 7668828. doi:10.1002/ana.410380312.

Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS (December 2001). "Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP". Nature 414 (6864): 643–8. PMID 11740561. doi:10.1038/414643a.

Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J (September 1999). "Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease". Am. J. Pathol. 155 (3): 853–62. PMC 1866907. PMID 10487842. doi:10.1016/S0002-9440(10)65184-X. Arquivado dende o orixinal o 15 de setembro de 2003. Consultado o 12 de marzo de 2014.

Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (April 2003). "Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis". Science 300 (5618): 486–9. Bibcode:2003Sci...300..486K. PMID 12702875. doi:10.1126/science.1079469.

Hartmann T, Bieger SC, Brühl B, Tienari PJ, Ida N, Allsop D, Roberts GW, Masters CL, Dotti CG, Unsicker K, Beyreuther K (September 1997). "Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides". Nat. Med. 3 (9): 1016–20. PMID 9288729. doi:10.1038/nm0997-1016.

Yin YI, Bassit B, Zhu L, Yang X, Wang C, Li YM (August 2007). "γ-Secretase Substrate Concentration Modulates the Aβ42/Aβ40 Ratio: Implications for Alzheimer's disease". J. Biol. Chem. 282 (32): 23639–44. PMID 17556361. doi:10.1074/jbc.M704601200.

Nalivaeva NN, Belyaev ND, Zhuravin IA, Turner AJ (2012). "The Alzheimer's amyloid-degrading peptidase, neprilysin: can we control it?". Int J Alzheimers Dis 2012: 383796. PMC 3412116. PMID 22900228. doi:10.1155/2012/383796.

Maslow K (March 2008). "2008 Alzheimer's disease facts and figures". Alzheimers Dement 4 (2): 110–33. PMID 18631956. doi:10.1016/j.jalz.2008.02.005.

Zhang S, Iwata K, Lachenmann MJ, Peng JW, Li S, Stimson ER, Lu Y, Felix AM, Maggio JE, Lee JP (June 2000). "The Alzheimer's peptide a beta adopts a collapsed coil structure in water". J. Struct. Biol. 130 (2-3): 130–41. PMID 10940221. doi:10.1006/jsbi.2000.4288.

Yang M, Teplow DB (December 2008). "Amyloid beta-protein monomer folding: free-energy surfaces reveal alloform-specific differences". J. Mol. Biol. 384 (2): 450–64. PMC 2673916. PMID 18835397. doi:10.1016/j.jmb.2008.09.039.

Sgourakis NG, Merced-Serrano M, Boutsidis C, Drineas P, Du Z, Wang C, Garcia AE (January 2011). "Atomic-level characterization of the ensemble of the Aβ(1-42) monomer in water using unbiased molecular dynamics simulations and spectral algorithms". J. Mol. Biol. 405 (2): 570–83. PMC 3060569. PMID 21056574. doi:10.1016/j.jmb.2010.10.015.

Sgourakis NG, Yan Y, McCallum SA, Wang C, Garcia AE (May 2007). "The Alzheimer's peptides Abeta40 and 42 adopt distinct conformations in water: a combined MD / NMR study". J. Mol. Biol. 368 (5): 1448–57. PMC 1978067. PMID 17397862. doi:10.1016/j.jmb.2007.02.093.

Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S, Aimoto S, Elliott JI, Van Nostrand WE, Smith SO (May 2010). "Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils". Nat. Struct. Mol. Biol. 17 (5): 561–7. PMC 2922021. PMID 20383142. doi:10.1038/nsmb.1799.

Yu L, Edalji R, Harlan JE, Holzman TF, Lopez AP, Labkovsky B, Hillen H, Barghorn S, Ebert U, Richardson PL, Miesbauer L, Solomon L, Bartley D, Walter K, Johnson RW, Hajduk PJ, Olejniczak ET (March 2009). "Structural characterization of a soluble amyloid beta-peptide oligomer". Biochemistry 48 (9): 1870–7. PMID 19216516. doi:10.1021/bi802046n.

Strodel B, Lee JW, Whittleston CS, Wales DJ (September 2010). "Transmembrane structures for Alzheimer's Aβ(1-42) oligomers". J. Am. Chem. Soc. 132 (38): 13300–12. PMID 20822103. doi:10.1021/ja103725c.

Mattson MP (August 2004). "Pathways towards and away from Alzheimer's disease". Nature 430 (7000): 631–9. PMC 3091392. PMID 15295589. doi:10.1038/nature02621.

Citron M (September 2004). "Strategies for disease modification in Alzheimer's disease". Nat. Rev. Neurosci. 5 (9): 677–85. PMID 15322526. doi:10.1038/nrn1495.

Winblad B, Andreasen N, Minthon L, Floesser A, Imbert G, Dumortier T, Maguire RP, Blennow K, Lundmark J, Staufenbiel M, Orgogozo JM, Graf A (June 2012). "Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study". Lancet Neurol 11 (7): 597–604. PMID 22677258. doi:10.1016/S1474-4422(12)70140-0. Resumo divulgativo – Karolinska Institutet.

Wang CM, Devries S, Camboni M, Glass M, Martin PT (September 2010). "Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease". Neurobiol. Dis. 39 (3): 409–22. PMC 2913404. PMID 20493257. doi:10.1016/j.nbd.2010.05.013.

Lashuel, H. A.; Hartley, D. M.; Balakhaneh, D.; Aggarwal A.; Teichberg S.; Callaway, D. J. E. (November 2002). "New class of inhibitors of amyloid-beta fibril formation. Implications for the mechanism of pathogenesis in Alzheimer's disease". J. Biol. Chem. 277 (45): 42881–90. PMID 12167652. doi:10.1074/jbc.M206593200.

Parker MH, Chen R, Conway KA, Lee DH, Luo C, Boyd RE, Nortey SO, Ross TM, Scott MK, Reitz AB (November 2002). "Synthesis of (-)-5,8-dihydroxy-3R-methyl-2R-(dipropylamino)-1,2,3,4-tetrahydronaphthalene: an inhibitor of beta-amyloid(1-42) aggregation". Bioorg. Med. Chem. 10 (11): 3565–9. PMID 12213471. doi:10.1016/S0968-0896(02)00251-1.

finder, v; glockshuber (2009). "The Recombinant Amyloid-β Peptide Aβ1–42 Aggregates Faster and Is More Neurotoxic than Synthetic Aβ1–42". journal of molecular biology 396: 9–18. doi:10.1016/j.jmb.2009.12.016.

Editor. "State of Aggregation". Nature Neuroscience 14: 399. doi:10.1038/nn0411-399.

Pappolla M, Bozner P, Soto C, Shao H, Robakis NK, Zagorski M, Frangione B, Ghiso J (March 1998). "Inhibition of Alzheimer's beta fibrillogenesis by melatonin". J Biol Chem 273 (13): 7185–7188. PMID 9516407. doi:10.1074/jbc.273.13.7185.

Lahiri DK, Chen DM, Lahiri P, Bondy S, Greig NH (November 2005). "Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseases". Ann. N. Y. Acad. Sci. 1056: 430–49. Bibcode:2005NYASA1056..430L. PMID 16387707. doi:10.1196/annals.1352.008.

Wang XC, Zhang YC, Chatterjie N, Grundke-Iqbal I, Iqbal K, Wang JZ (June 2008). "Effect of melatonin and melatonylvalpromide on beta-amyloid and neurofilaments in N2a cells". Neurochem. Res. 33 (6): 1138–44. PMID 18231852. doi:10.1007/s11064-007-9563-y.

Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM (November 2009). "Amyloid-β Dynamics are Regulated by Orexin and the Sleep-Wake Cycle". Science 326 (5955): 1005–7. Bibcode:2009Sci...326.1005K. PMC 2789838. PMID 19779148. doi:10.1126/science.1180962. Resumo divulgativo – News-Medical.Net.

Ramírez BG, Blázquez C, Gómez del Pulgar T, Guzmán M, de Ceballos ML (February 2005). "Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation". J. Neurosci. 25 (8): 1904–13. PMID 15728830. doi:10.1523/JNEUROSCI.4540-04.2005.

Milton NG (October 2002). "Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide". Neurosci. Lett. 332 (2): 127–30. PMID 12384227. doi:10.1016/S0304-3940(02)00936-9.

Lee JY, Cole TB, Palmiter RD, Suh SW, Koh JY (May 2002). "Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice". Proc. Natl. Acad. Sci. U.S.A. 99 (11): 7705–10. Bibcode:2002PNAS...99.7705L. PMC 124328. PMID 12032347. doi:10.1073/pnas.092034699.

Schneider JS, Pioli EY, Jianzhong Y, Li Q, Bezard E (April 2013). "Effects of memantine and galantamine on cognitive performance in aged rhesus macaques". Neurobiol. Aging 34 (4): 1126–32. PMID 23158762. doi:10.1016/j.neurobiolaging.2012.10.020.

McClean, P., Parthsarathy, V., Faivre, E., and Hölscher, C (November 2011). "The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease". The Journal of Neuroscience 31 (17): 6587–6594. PMID 12213471. doi:10.1016/S0968-0896(02)00251-1.

Volicer L, Harper D, Manning B, Goldstein R, Satlin A (2001). "Sundowning and circadian rhythms in Alzheimer's disease". Am J Psychiatry 158 (5): 704–11. PMID 11329390. doi:10.1176/appi.ajp.158.5.704.

Schmidt SD, Nixon RA, Mathews PM (2012). "Tissue processing prior to analysis of Alzheimer's disease associated proteins and metabolites, including Aβ". Methods Mol. Biol. Methods in Molecular Biology 849: 493–506. ISBN 978-1-61779-550-3. PMID 22528111. doi:10.1007/978-1-61779-551-0_33.

Schmidt SD, Mazzella MJ, Nixon RA, Mathews PM (2012). "Aβ measurement by enzyme-linked immunosorbent assay". Methods Mol. Biol. Methods in Molecular Biology 849: 507–527. ISBN 978-1-61779-550-3. PMID 22528112. doi:10.1007/978-1-61779-551-0_34.

Stine WB, Dahlgren KN, Krafft GA, LaDu MJ (March 2003). "In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis". J. Biol. Chem. 278 (13): 11612–22. PMID 12499373. doi:10.1074/jbc.M210207200.

Gengler S, Gault VA, Harriott P, Hölscher C (June 2007). "Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background". Exp Brain Res 179 (4): 621–30. PMID 17171334. doi:10.1007/s00221-006-0819-6.

Rekas A, Jankova L, Thorn DC, Cappai R, Carver JA (December 2007). "Monitoring the prevention of amyloid fibril formation by alpha-crystallin. Temperature dependence and the nature of the aggregating species". FEBS J. 274 (24): 6290–304. PMID 18005258. doi:10.1111/j.1742-4658.2007.06144.x.

Sanghera N, Swann MJ, Ronan G, Pinheiro TJ (October 2009). "Insight into early events in the aggregation of the prion protein on lipid membranes". Biochim. Biophys. Acta 1788 (10): 2245–51. PMID 19703409. doi:10.1016/j.bbamem.2009.08.005.

ki.se

nih.gov

ncbi.nlm.nih.gov

Nussbaum, J. M.; Seward, M. E.; Bloom, G. S. (2013). "Alzheimer disease: A tale of two prions". Prion 7 (1): 14–9. doi:10.4161/pri.22118. PMC 3609044. PMID 22965142.

Sarkar IN, Tharp G (April 2013). "Origins of amyloid-beta.". BMC Genomics 14 (1): 290. PMID 23627794. doi:10.1186/1471-2164-14-290.

Zou K, Gong JS, Yanagisawa K, Michikawa M (June 2002). "A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage". J. Neurosci. 22 (12): 4833–41. PMID 12077180.

Yao ZX, Papadopoulos V (October 2002). "Function of beta-amyloid in cholesterol transport: a lead to neurotoxicity". FASEB J. 16 (12): 1677–9. PMID 12206998. doi:10.1096/fj.02-0285fje.

Zhao LN, Long H, Mu Y, Chew LY (2012). "The Toxicity of Amyloid β Oligomers". Int J Mol Sci 13 (6): 7303–27. PMC 3397527. PMID 22837695. doi:10.3390/ijms13067303.

Ghiso J, Frangione B (December 2002). "Amyloidosis and Alzheimer's disease". Adv. Drug Deliv. Rev. 54 (12): 1539–51. PMID 12453671. doi:10.1016/S0169-409X(02)00149-7.

Selkoe DJ (October 2001). "Clearing the brain's amyloid cobwebs". Neuron 32 (2): 177–80. PMID 11683988. doi:10.1016/S0896-6273(01)00475-5.

Xie L, Helmerhorst E, Taddei K, Plewright B, Van Bronswijk W, Martins R (May 2002). "Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor" (PDF). J. Neurosci. 22 (10): RC221. PMID 12006603.

Roberts SB (December 2002). "γ-secretase inhibitors and Alzheimer's disease". Adv. Drug Deliv. Rev. 54 (12): 1579–88. PMID 12453675. doi:10.1016/S0169-409X(02)00155-2.

Vassar R (December 2002). "Beta-secretase (BACE) as a drug target for Alzheimer's disease". Adv. Drug Deliv. Rev. 54 (12): 1589–602. PMID 12453676. doi:10.1016/S0169-409X(02)00157-6.

Zlokovic BV, Frangione B (2003). Transport-clearance hypothesis for Alzheimer’s disease and potential therapeutic implications. Landes Bioscience. pp. 114–122.

Maslow K (March 2008). "2008 Alzheimer's disease facts and figures". Alzheimers Dement 4 (2): 110–33. PMID 18631956. doi:10.1016/j.jalz.2008.02.005.

Mattson MP (August 2004). "Pathways towards and away from Alzheimer's disease". Nature 430 (7000): 631–9. PMC 3091392. PMID 15295589. doi:10.1038/nature02621.

Citron M (September 2004). "Strategies for disease modification in Alzheimer's disease". Nat. Rev. Neurosci. 5 (9): 677–85. PMID 15322526. doi:10.1038/nrn1495.

Beta-amiloide (Galician Wikipedia)

amidebio.com

amjpathol.org

ajp.amjpathol.org

archive.org

archive.today

dddmag.com

doi.org

dx.doi.org

foxnews.com

harvard.edu

adsabs.harvard.edu

jneurosci.org

ki.se

news-medical.net

nih.gov

ncbi.nlm.nih.gov